The novel coronavirus disease (COVID-19) generated significant health concerns worldwide, leading policymakers and health care experts to implement nonpharmaceutical public health interventions to mitigate the spread of the virus. While these interventions played a crucial role in controlling transmission, they also resulted in substantial economic and societal costs, necessitating strategic deployment, particularly during periods of increasing disease activity. In this context, geosocial med...
